Cholesterol plays a vital role in the body, providing structural support to cells and serving as a building block for hormone ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver ...

Fatty liver disease, now termed MASLD, is increasingly prevalent, particularly among those with weight issues, diabetes, or ...

Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

Madrigal Pharmaceuticals secures global rights to SYH2086, aiming to enhance MASH treatment with innovative combination ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

The idea is that SYH2086 can be paired with Rezdiffra, a selective thyroid hormone receptor agonist that became the first FDA-approved drug for metabolic dysfunction-associated steatohepatitis (MASH) ...